You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Transitional Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

Not yet recruiting
  • Urothelial Carcinoma
  • +7 more
  • Jelmyto (mitomycin) for pyelocalyceal solution
  • (no location specified)
May 22, 2023

Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)

Not yet recruiting
  • Urothelial Carcinoma of the Renal Pelvis and Ureter
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • (no location specified)
Nov 7, 2023

Immunotherapy in Upper Tract Urothelial Carcinoma

Not yet recruiting
  • Urothelial Carcinoma
  • Evaluation of anti-PD-(L)1 immunotherapy efficacy
  • (no location specified)
Oct 27, 2023

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

18F-LN1 PET/CT in Urothelial Carcinomas

Recruiting
  • Urothelial Carcinoma
    • Chengdu, Sichuan, China
      Departments of Nuclear Medicine, Sichuan Provincial People's Hos
    Nov 2, 2023

    Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

    Not yet recruiting
    • Urothelial Carcinoma
    • +2 more
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jun 27, 2023

    Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)

    Not yet recruiting
    • Urothelial Carcinoma Ureter
    • Urothelial Cancer of Renal Pelvis
    • Mitomycin C
    • (no location specified)
    Jul 31, 2023

    Hematuria, Urothelial Tumor, Urothelial Carcinoma Trial in Rotterdam (urine-first strategy)

    Recruiting
    • Hematuria
    • +3 more
    • urine-first strategy
    • Rotterdam, Netherlands
      SeARCH-trial Pijpers
    Aug 30, 2023

    Nivolumab in Japanese Muscle-invasive Urothelial Carcinoma

    Not yet recruiting
    • Muscle-invasive Urothelial Carcinoma
      • City, State, Japan
        Local Institution
      Mar 20, 2023

      Stratification in Veterans Presenting With Microscopic Hematuria

      Not yet recruiting
      • Urothelial Carcinoma
      • Cxbladder urine test
      • Durham, North Carolina
        Durham VA Health Care System
      Jun 1, 2023

      Metastatic Urothelial Carcinoma Trial in Guangzhou (utidelone injection)

      Recruiting
      • Metastatic Urothelial Carcinoma
      • utidelone injection
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      May 29, 2023

      Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

      Recruiting
      • Urothelial Carcinoma
      • Non-Invasive Bladder Urothelial Carcinoma
      • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
      • Tampa, Florida
        Moffitt Cancer Center
      Mar 2, 2023

      Biomarkers in Bladder Urothelial Carcinoma

      Completed
      • Bladder Cancer
      • Free glycosaminoglycan profiling
      • Gothenburg, Sweden
        Department of Urology, Institute of Clinical Science, Sahlgrensk
      Apr 3, 2023

      HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

      Not yet recruiting
      • Urothelial Carcinoma
        • (no location specified)
        Jun 5, 2023

        Liquid Biospy for Urinary Cancers

        Recruiting
        • Urothelial Carcinoma
        • Genetic analysis on isolated cells
        • Milan, Italy
          Urology Department
        Nov 6, 2023

        Neoadjuvant Chemotherapy in Upper Tract Urothelial Carcinoma

        Not yet recruiting
        • Upper Excretory Tract Tumors
        • Patients with Upper excretory tract tumors
        • (no location specified)
        Jan 3, 2023

        Urothelial Carcinoma Trial (Avelumab)

        Not yet recruiting
        • Urothelial Carcinoma
        • (no location specified)
        Oct 26, 2022

        Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

        Not yet recruiting
        • Advanced Solid Tumor
        • +15 more
        • (no location specified)
        Jun 2, 2023

        Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)

        Not yet recruiting
        • Metastatic Urothelial Carcinoma
        • Pembrolizumab (200mg)
        • +2 more
        • (no location specified)
        Sep 18, 2023

        Primary and Metastatic Tumors in Renal Cell Carcinoma and

        Recruiting
        • Renal Cell Carcinoma
        • +4 more
        • Immune checkpoint inhibitor targeting PD1
        • Philadelphia, Pennsylvania
          Fox Chase Cancer Center - Philadelphia
        Jan 27, 2023

        18F-HER2 PET Trial in Hangzhou (18F-HER2 PET)

        Not yet recruiting
        • 18F-HER2 PET
        • 18F-HER2 PET
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, Zhejiang University School of med
        Aug 2, 2023

        Urothelial Carcinoma Trial in Gainesville (Mitomycin c)

        Active, not recruiting
        Has Results
        • Urothelial Carcinoma
        • Mitomycin c
        • Gainesville, Florida
          University of Florida
        Dec 6, 2022

        A Prospective, Multi-center Study

        Not yet recruiting
        • Hematuria
        • Urothelial Carcinoma
        • urine sample collection
        • Shanghai, Shanghai, China
          Changhai Hospital
        May 29, 2023

        Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

        Not yet recruiting
        • Urinary Bladder Neoplasms
          • (no location specified)
          Feb 14, 2023

          Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)

          Not yet recruiting
          • Advanced Solid Tumors Cancer
          • +3 more
          • New York, New York
            Memorial Slone Kettering Cancer Center
          Jun 26, 2023